+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

R

Actively Recruiting

Epstein-Barr Virus EBV infects about 95% of adults worldwide and can lead to various conditions including infectious mononucleosis, chronic fatigue syndrome, and certain malignancies. Most EBV infections do not show symptoms due to effective immune responses. This study aims to evaluate the effects of two drugs, 2LEBV4 and 2LXFS4, compared to placebo in reducing fatigue and other symptoms associated with EBV infection. Participants will take one capsule daily of either 2LEBV4, 2LXFS4, or placebo for six continuous months. The capsules are taken sequentially according to their number on the blister pack. This treatment schedule is the same for both drugs and placebo, ensuring a consistent dosing routine during the study period. Throughout the six months, participants will be monitored for fatigue levels using the Multidimensional Fatigue Inventory-20 questionnaire and other EBV-related symptoms. Researchers will compare symptom changes and immune cell markers between treatment and placebo groups. Safety will be assessed by recording any adverse events. The studys total duration allows for comprehensive evaluation of treatment effects on EBV symptoms.

Age: 12Years +All GendersPhase 4
8 locations
S

Actively Recruiting

Researchers are collecting detailed data about suicide attempts and suicidal thoughts among people who come to healthcare services in Flanders. The study aims to understand how often these behaviors occur, the methods used, and how many receive proper follow-up care after a suicide attempt. This observational study uses a structured interview tool called the Guideline for Suicide Care and Evaluation LOES to gather comprehensive information. Participants undergo a two-part semi-structured interview administered by trained nurses, psychologists, or psychiatrists. The first part happens soon after admission to a healthcare facility and collects information on emotional state, mental health history, social support, hopelessness, and suicidal behavior. The second part provides a deeper evaluation of risk factors, treatment needs, motivations, planning, and coping strategies related to suicidality. Throughout the study, participants provide demographic, clinical, and psychological information through interviews. Researchers assess suicidal intent, planning, past behavior, substance use risk, and care needs. The study tracks treatment agreements and care pathways after assessment. Data collection occurs at the initial presentation, with no drug or medical treatment being tested. The total participation time varies depending on the individuals healthcare encounters and follow-up.

Age: 12Years +All Genders
33 locations